DrugChip®

Genetic differences between individuals influence their response to drugs.  Pharmacogenetic studies allow tailoring every treatment according to the individual's genetics,  in order to maximize efficiency and minimize adverse effects.

DrugChip® analyzes the two groups of genes involved in:

DRUGS PHARMACODINAMICS PROPERTIES

How the drug works in our body.

Determine the effectiveness of the drug.

DRUGS PHARMACOKINETICS PROPERTIES

How the body modifies the drug.

Determine the drug's toxicity.

PHARMACODINAMICS
PHARMACOKINETICS

Receivers

Ion channels

Enzymes

Immune system

Absorption

Distribution

Metabolism

Excretion

OBJECTIVE: 
Select the best drug using genetic information to: Minimize secondary effects and Maximize therapeutic efficacy

DrugChip® is directed to the treatment of:

  • DrugChip® Neuro  Neuropsychiatric disorders, depression, psychosis, anxiety and insomnia and epilepsy.
  • DrugChip® Cardio Cardiovascular disease and hypertension
  • DrugChip® Onco Different cancer type.